CMPX vs VFC · $367.4M cap vs P/E 26, rev $9.50B
Compass Therapeutics Inc. (CMPX) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
CMPX currently screens at market cap $367.4M. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the CMPX and VFC stock pages for the full models.
Not investment advice.